BACKGROUND: Intra-arterial (IA) thrombectomy for acute ischemic stroke has an excellent recanalization rate but variable outcomes. The core infarct also grows at a variable rate despite recanalization. We aim to study the factors that are associated with infarct growth after IA therapy. METHODS: We reviewed the hyperacute ischemic stroke imaging database at Cleveland Clinic for those undergoing endovascular thrombectomy of anterior circulation from 2009 to 2012. Patients with both pretreatment and follow-up magnetic resonance imaging were included. Seventy-six patients were stratified into quartiles by infarct volume growth from initial to follow-up diffusion-weighted imaging (DWI) measure by a region of interest demarcation. RESULTS: The median infarct growth of each quartile was .6 cm(3) (no-growth group), 13.8, 37, and 160.2 cm(3) (large-growth group). Pretreatment stroke severity was comparable among groups. Compared with the no-growth group, the large-growth group had larger initial infarct defined by computed tomography (CT) Alberta Stroke Program Early CT score (median 10 versus 8, P = .032) and DWI volume (mean 13.8 versus 29.2 cm(3), P = .034), lack of full collateral vessels on CT angiography (36.8% versus 0%, P = .003), and a lower recanalization rate (thrombolysis in cerebral infarction ≥2b, P = .044). The increase in infarct growth is associated with decrease in favorable outcomes defined by a modified Rankin Scale score of 0-2 at 30 days: 57.9%, 42.1%, 21.1%, and 5.3%, respectively (P < .001). DWI reversal was observed in 11 of 76 patients, translating to 82% favorable outcome. CONCLUSIONS: Infarct evolution after endovascular thrombectomy is associated with an outcome. DWI reversal or no growth translated to a favorable outcome. Small initial ischemic core, good collateral support, and better recanalization grades predict the smaller infarct growth and favorable outcome after endovascular thrombectomy.
BACKGROUND: Intra-arterial (IA) thrombectomy for acute ischemic stroke has an excellent recanalization rate but variable outcomes. The core infarct also grows at a variable rate despite recanalization. We aim to study the factors that are associated with infarct growth after IA therapy. METHODS: We reviewed the hyperacute ischemic stroke imaging database at Cleveland Clinic for those undergoing endovascular thrombectomy of anterior circulation from 2009 to 2012. Patients with both pretreatment and follow-up magnetic resonance imaging were included. Seventy-six patients were stratified into quartiles by infarct volume growth from initial to follow-up diffusion-weighted imaging (DWI) measure by a region of interest demarcation. RESULTS: The median infarct growth of each quartile was .6 cm(3) (no-growth group), 13.8, 37, and 160.2 cm(3) (large-growth group). Pretreatment stroke severity was comparable among groups. Compared with the no-growth group, the large-growth group had larger initial infarct defined by computed tomography (CT) Alberta Stroke Program Early CT score (median 10 versus 8, P = .032) and DWI volume (mean 13.8 versus 29.2 cm(3), P = .034), lack of full collateral vessels on CT angiography (36.8% versus 0%, P = .003), and a lower recanalization rate (thrombolysis in cerebral infarction ≥2b, P = .044). The increase in infarct growth is associated with decrease in favorable outcomes defined by a modified Rankin Scale score of 0-2 at 30 days: 57.9%, 42.1%, 21.1%, and 5.3%, respectively (P < .001). DWI reversal was observed in 11 of 76 patients, translating to 82% favorable outcome. CONCLUSIONS:Infarct evolution after endovascular thrombectomy is associated with an outcome. DWI reversal or no growth translated to a favorable outcome. Small initial ischemic core, good collateral support, and better recanalization grades predict the smaller infarct growth and favorable outcome after endovascular thrombectomy.
Authors: Ronen R Leker; Asaf Honig; Andrei Filioglo; Naaem Simaan; John M Gomori; Jose E Cohen Journal: Neuroradiology Date: 2020-10-06 Impact factor: 2.804
Authors: Gregoire Boulouis; Arne Lauer; Ahmer Khawdja Siddiqui; Andreas Charidimou; Robert W Regenhardt; Anand Viswanathan; Natalia Rost; Thabele M Leslie-Mazwi; Lee H Schwamm Journal: JAMA Neurol Date: 2017-11-01 Impact factor: 18.302
Authors: Seyedmehdi Payabvash; Nils H Petersen; Khalid Al-Dasuqi; Gerardo A Torres-Flores; Sumita M Strander; Cindy Khanh Nguyen; Krithika U Peshwe; Sreeja Kodali; Andrew Silverman; Ajay Malhotra; Michele H Johnson; Charles C Matouk; Joseph L Schindler; Lauren H Sansing; Guido J Falcone; Kevin N Sheth Journal: Stroke Date: 2020-08-12 Impact factor: 7.914
Authors: Claus Z Simonsen; Irene K Mikkelsen; Sanja Karabegovic; Pia Kjaer Kristensen; Albert J Yoo; Grethe Andersen Journal: Front Neurol Date: 2017-10-30 Impact factor: 4.003
Authors: Kersten Villringer; Sascha Zimny; Ivana Galinovic; Christian H Nolte; Jochen B Fiebach; Ahmed A Khalil Journal: Front Neurol Date: 2019-10-25 Impact factor: 4.003
Authors: Robert W Regenhardt; Mark R Etherton; Alvin S Das; Markus D Schirmer; Joshua A Hirsch; Christopher J Stapleton; Aman B Patel; Thabele M Leslie-Mazwi; Natalia S Rost Journal: J Neuroimaging Date: 2020-10-29 Impact factor: 2.486